IA
NVO

IFC Advisors’s Novo Nordisk NVO Stock Holding History

IFC Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,582
Closed -$247K – 174
2025
Q2 		$247K Sell
3,582
-219
-6% -$14.9K 0.05% 156
2025
Q1 		$264K Buy
3,801
+1,470
+63% +$121K 0.06% 139
2024
Q4 		$201K Buy
+2,331
New +$252K 0.04% 140

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IFC Advisors's NVO Position: Q3 2025 in Review

IFC Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,582 shares — an estimated $247K sold.

IFC Advisors first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $264K in Q1 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • IFC Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • IFC Advisors sold 3,582 Novo Nordisk shares in Q3 2025, an estimated $247K.
  • IFC Advisors first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
  • IFC Advisors's Novo Nordisk position peaked at $264K in Q1 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on IFC Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.